UNC Researchers Team Up to Find New Target for Dengue Virus VaccineInfection Control TodayCreating a vaccine that protects people from all four types of dengue virus has frustrated scientists for decades. But researchers at the University of North Caro…
Immunomedics Extends Patent Life on Therapeutic Antibodies – NASDAQ
Immunomedics Extends Patent Life on Therapeutic AntibodiesNASDAQMORRIS PLAINS, N.J., Feb. 26, 2014 (GLOBE NEWSWIRE) — Immunomedics, Inc.(Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based produc…
Immunomedics Extends Patent Life on Therapeutic Antibodies – GlobeNewswire (press release)
|
Immunomedics Extends Patent Life on Therapeutic Antibodies
GlobeNewswire (press release) 8,658,773, which protects a method of concentrating antibodies for subcutaneous, intramuscular or transdermal administration. The patent covers all of the Company’s therapeutic antibodies, and can also be applied to most other antibodies, permitting a … |
Immunomedics Extends Patent Life on Therapeutic Antibodies – Virtual-Strategy Magazine (press release)
Immunomedics Extends Patent Life on Therapeutic AntibodiesVirtual-Strategy Magazine (press release)MORRIS PLAINS, N.J., Feb. 26, 2014 (GLOBE NEWSWIRE) — Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development…
Immunomedics Extends Patent Life on Therapeutic Antibodies – Wall Street Journal
Immunomedics Extends Patent Life on Therapeutic AntibodiesWall Street JournalMORRIS PLAINS, N.J., Feb. 26, 2014 (GLOBE NEWSWIRE) — Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibod…
Immunomedics Extends Patent Life on Therapeutic Antibodies – MarketWatch
|
Immunomedics Extends Patent Life on Therapeutic Antibodies
MarketWatch 8,658,773, which protects a method of concentrating antibodies for subcutaneous, intramuscular or transdermal administration. The patent covers all of the Company’s therapeutic antibodies, and can also be applied to most other antibodies, permitting a … Immunomedics to Present at Cowen and Company 34th Annual Health Care …Virtual-Strategy Magazine (press release) |
Sisters junior eyes medical career – Bend Bulletin
|
Sisters junior eyes medical career
Bend Bulletin One of the speakers was a woman who’d been burned by acid and underwent a first-of-its-kind face transplant surgery. “It’s an amazing idea that you could do that for someone,” Maddi said. “That you could make that big of an impact on somebody. One of … |
Transplant drugs may cause body to reject new lungs – Futurity: Research News
GPB |
Transplant drugs may cause body to reject new lungs
Futurity: Research News Researchers found mice were more likely to reject newly transplanted lungs if key immune cells were missing, a situation that simulates what happens when patients take immunosuppressive drugs. These “memory T cells” are primed to “remember” … New clues found to preventing lung transplant rejectionWashington University in St. Louis News |
Prior resection poses certain risks in lung transplantation – The Oncology Report
|
Prior resection poses certain risks in lung transplantation
The Oncology Report ORLANDO – Prior lung resection is associated with increased early mortality and with a more than twofold increased risk of renal failure requiring dialysis in lung transplant recipients, data from the United Network for Organ Sharing suggest. Prior … |
CORDIS – THYMISTEM researches stem cell therapies for damaged immune … – DeHavilland (press release) (subscription)
CORDIS – THYMISTEM researches stem cell therapies for damaged immune …DeHavilland (press release) (subscription)The thymus plays a central role in the development of our immune system by producing important immune cells. However, this crucial organ d…